MedPath

Therapeutic range of Brivaracetam, a historical observational study to define a therapeutic range

Conditions
G40.2
G40
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
Epilepsy
Registration Number
DRKS00012584
Lead Sponsor
Epilepsiezentrum Kork
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Retrospective analysis of already available data during the period of 01.03.2016 - 15.05.2017 of patients with age between 18 and 89 years and a diagnosis of epilepsy and a treatment of brivaracetam

Exclusion Criteria

1. Healthy volunteers
2. Data from the following patients will NOT be collected: minors, mentally disabled patients, dementia patients, pregnant women, breastfeeding or emergency patients.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath